Condition
Obesity
Overweight
Locations
United States
Start date
01/05/2026
Identifiers
Trial ID NN9695-8150,
NCT number NCT07566390,
Eudract number Not Available
NCT number NCT07566390,
Eudract number Not Available
Summary
The purpose of this clinical study is to find out if NNC0113-5840 is safe for treating people with excess body weight. There are 2 study treatments in this study, participants will get either NNC0113-5840 (the product being tested) or Placebo (treatment that has no active medicine in it), Which treatment participants get is decided by chance.
Trial Overview:
Treatment
DRUG: NNC0113-5840
DRUG: Placebo
Study type
INTERVENTIONAL
Trial duration
May 01 2026 - Jan 31 2027
Participants
48
Phase
I
Are you eligible?
Gender
Male and female
Age
18 to 55 years old
Find out how you can participate
Questions or concerns
Do you have any question about what it’s like being a clinical volunteer? Have a look at our answers to frequently asked questions.
This site contains information about clinical trials sponsored by Novo Nordisk. It is not intended to replace the advice of a healthcare professional and should not be construed as providing advice or making a recommendation. The information on this site should not be relied on as the basis for any decision or action. Only a physician can determine whether a specific product is correct for a particular patient. If you have questions regarding any information contained on this site you should consult a physician.